| Δ9-THC | Δ9-tetrahydrocannabinol |
| Δ9-THCP | Δ9-tetrahydrocannabiphorol |
| ACEA | Arachidonyl-2′-chloroethylamide |
| ACPA | Arachidonylcyclopropylamide |
| AEA | Anandamide or arachidonoylethanolamide |
| AM-251 | 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide |
| AM-281 | 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide |
| AM-630 | [6-iodo-2-methyl-1-(2-morpholin-4-ylethyl)indol-3-yl]-(4-methoxyphenyl)methanone or 6-iodopravadoline |
| CBD | Cannabidiol |
| CBDP | Cannabidiphorol |
| Compound C2 | N-[5-bromo-1,2-dihydro-1-(4′-fluorobenzyl)-4-methyl-2-ox-opyridin-3yl]cycloheptanecarboxamide |
| CP-55,940 | 2-[(1R,2R,5R)-5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol |
| GAT211 | 3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole |
| GAT229 | S-(-)-3-(2-nitro-1-phenylethyl)-2-phenyl-1H-indole |
| GW-405833 | (2,3-dichlorophenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-ylethyl)indol-1-yl]methanone |
| HK | High potassium solution (96mM KCl, 2 mM NaCl, 1 mMMgCl2, 1.8mM CaCl2, 5mM HEPES with a final pH of 7.5) |
| HU-210 | (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a tetrahydrobenzo[c]chromen-1-ol or 11-hydroxy-Δ8-THC-dimethylheptyl |
| HU-308 | [(1S,4S,5S)-4-[2,6-dimethoxy-4-(2-methyloctan-2-yl)phenyl]-6,6-dimethyl-2-bicyclo [3.1.1]hept-2-enyl]methanol |
| JWH-015 | (2-methyl-1-propylindol-3-yl)-naphthalen-1-ylmethanone |
| JWH-133 | (6aR,10aR)-6,6,9-trimethyl-3-(2-methylpentan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene |
| L-759633 | (6aR,10aR)-1-methoxy-6,6,9-trimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene |
| L-759656 | (6aR,10aR)-1-methoxy-6,6-dimethyl-9-methylidene-3-(2-methyloctan-2-yl)-7,8,10,10a-tetrahydro-6aH-benzo[c]chromene |
| ND96 | Physiological salt buffer solution (96 mM NaCl, 2 mM MgCl2, 2 mM KCl, 5 mM HEPES, and 1.8 mM CaCl2, with a final pH of 7.5) |
| Org27569 | 5-chloro-3-ethyl-N-[2-(4-piperidin-1-ylphenyl)ethyl]-1H-indole-2-carboxamide |
| Org27759 | N-[2-[4-(dimethylamino)phenyl]ethyl]-3-ethyl-5-fluoro-1H-indole-2-carboxamide |
| Org29647 | N-[(3R)-1-benzylpyrrolidin-3-yl]-5-chloro-3-ethyl-1H-indole-2-carboxamide;(E)-but-2-enedioic acid |
| PM-226 | 9-methoxy-4,4-dimethyl-7-(2-methyloctan-2-yl)chromeno[3,4-d][1,2]oxazole |
| PSNCBAM-1 | 1-(4-chlorophenyl)-3-[3-(6-pyrrolidin-1-ylpyridin-2-yl)phenyl]urea |
| Rimonabant or SR141716 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide |
| RTI-371 | 3-(4-chlorophenyl)-5-[(1R,2S,3S,5S)-8-methyl-3-(4-methylphenyl)-8-azabicyclo[3.2.1]octan-2-yl]-1,2-oxazole |
| SR144528 | 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethyl-2-bicyclo[2.2.1]heptanyl]pyrazole-3-carboxamide |
| Surinabant or SR147778 | 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-piperidin-1-ylpyrazole-3-carboxamide |
| Taranabant or MK-0364 | N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide |
| THC | Tetrahydrocannabinol |
| WIN-55,212-2 | [(11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone |
| ZCZ011 | 6-methyl-3-(2-nitro-1-thiophen-2-ylethyl)-2-phenyl-1H-indole |